Evidence map›Paper›PMID 39335682›Full record

ArticleDiagnostics (Basel, Switzerland)2024

Analytical Validation of Esopredict, an Epigenetic Prognostic Assay for Patients with Barrett's Esophagus.

Sarah Laun, Francia Pierre, Suji Kim, Daniel Lunz, Tara Maddala, Jerome V Braun, Stephen J Meltzer, Lisa Kann

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Diagnostic and Prognostic Biomarkers for Barrett's Esophagus.Gastroenterology clinics of North America · 2026
    Review
  2. Review
  3. Emerging Biomarkers for Managing Barrett's Esophagus.Gastrointestinal endoscopy clinics of North America · 2026
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sarah LaunPrevise, Halethorpe, MD 21227, USA.
Francia PierrePrevise, Halethorpe, MD 21227, USA.
Suji KimPrevise, Halethorpe, MD 21227, USA.
Daniel LunzPrevise, Halethorpe, MD 21227, USA.
Tara MaddalaPrevise, Halethorpe, MD 21227, USA.
Jerome V BraunPrevise, Halethorpe, MD 21227, USA.
Stephen J MeltzerDivision of Gastroenterology and Hepatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.ORCID 0000-0002-9131-1052
Lisa KannPrevise, Halethorpe, MD 21227, USA.

Funding

Academic-Industrial Partnership for Non-invasive Barrett's Esophagus DetectionR01DK118250 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI MELTZER, STEPHEN J · 2018 to 2022
$3.8M
Academic-Industrial Partnership for Barrett's Esophagus Detection and Risk AssessmentR01CA287294 · NCI · JOHNS HOPKINS UNIVERSITY · PI Stephen J Meltzer · 2024 to 2026
$2.3M
Validation and Early Commercialization of the ENVISAGE Assay, a Prognostic Test for Barrett's EsophagusR44DK136424 · NIDDK · CAPSULOMICS, LLC · PI LAUN, SARAH · 2023 to 2024
$1.8M
NIH HHS 1R01CA287294-23A1NIH HHS 1R01DK118250-22A5NIH HHS 1R44DK136424-23A1
6 · The paper itself

Abstract

Esopredict

Indexed as

Barrett’s esophagus (BE)EACHGDprognostic assay

Identifiers

PMID39335682
PMCPMC11431466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.